Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Standard
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial. / Weisel, Katja C; Scheid, Christof; Zago, Manola; Besemer, Britta; Mai, Elias K; Haenel, Mathias; Duerig, Jan; Munder, Markus; Lindemann, Hans-Walter; Seckinger, Anja; Kunz, Christina; Benner, Axel; Hose, Dirk; Jauch, Anna; Salwender, Hans; Goldschmidt, Hartmut.
In: BLOOD CANCER J, Vol. 9, No. 4, 08.04.2019, p. 45.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
AU - Weisel, Katja C
AU - Scheid, Christof
AU - Zago, Manola
AU - Besemer, Britta
AU - Mai, Elias K
AU - Haenel, Mathias
AU - Duerig, Jan
AU - Munder, Markus
AU - Lindemann, Hans-Walter
AU - Seckinger, Anja
AU - Kunz, Christina
AU - Benner, Axel
AU - Hose, Dirk
AU - Jauch, Anna
AU - Salwender, Hans
AU - Goldschmidt, Hartmut
N1 - Letter
PY - 2019/4/8
Y1 - 2019/4/8
KW - Journal Article
U2 - 10.1038/s41408-019-0206-8
DO - 10.1038/s41408-019-0206-8
M3 - Other (editorial matter etc.)
C2 - 30962424
VL - 9
SP - 45
JO - BLOOD CANCER J
JF - BLOOD CANCER J
SN - 2044-5385
IS - 4
ER -